Trump administration has quietly throttled an agency devoted to the safety of American healthcare
The Agency for Healthcare Research and Quality is currently seeing a massive shift in operations under the Trump administration. Federal records indicate that the agency has halted at least 104 active research grants. While Congress appropriated $345 million for AHRQ this fiscal year, the agency has spent less than $15 million on grants and has not issued a new one in over a year. The impact on the medical community is immediate, with researchers across the country reporting the sudden cancellation of projects aimed at patient safety, infection control, and pediatric care.
Internal staffing numbers have also dropped significantly. HHS reports that approximately 75% of AHRQ employees have been fired or resigned since the start of last year. Key leadership roles, including all grant managers, remain vacant. This restructuring has left many long-term research initiatives without support or oversight. Critics point out that the agency's work historically aligned with goals such as reducing medical errors and lowering healthcare costs, making the current shutdown difficult for many experts to reconcile with official stated priorities.
Director Roger Klein maintains that the agency is reviewing its processes and aligning with its statutory mission. However, researchers who received cancellation notices state that their work directly addresses the agency's stated goals regarding health outcomes and digital health tools. Some experts observe that the lack of new grant activity and the dismissal of staff suggest a permanent change in the function of the agency rather than a temporary pause.
The broader consequences for the healthcare sector remain unclear. AHRQ-funded research has long provided the foundation for national hospital surveys and clinical guidelines used by federal programs. With the U.S. Preventive Services Task Force currently understaffed and limited in its meeting frequency, the link between medical evidence and coverage decisions faces disruption. As private foundations become inundated with new applications from displaced scientists, the future of federally supported health services research continues to draw scrutiny from professional organizations and lawmakers.